In March of 2019, the U.S. Food and Drug Administration (FDA) approved Spravato, a nasal spray comprised of ketamine to help treat depression. This psychedelic prescription is unique because a single dose can have beneficial effects in a few hours and can continue to help for weeks. The cause of depression at the neuro level…